Thromboembolic prophylaxis in head trauma and multiple-trauma patients

Area of Science:

• Trauma Surgery
• Vascular Medicine
• Critical Care

Background:

• Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism, is a significant cause of mortality in trauma patients.
• The risk of DVT in trauma patients without prophylaxis exceeds 50%, and even with prophylaxis, one-third may still develop DVT.
• Prescribing DVT prophylaxis is often delayed due to concerns about increased bleeding risk in injured tissues.

Purpose of the Study:

• To review the evidence supporting the routine use of VTE prophylaxis in trauma patients.
• To discuss the safety, efficacy, and cost-effectiveness of pharmacological and mechanical VTE prophylaxis strategies.
• To emphasize the importance of timely VTE prophylaxis in improving patient outcomes.

Main Methods:

• Review of existing literature on VTE prophylaxis in trauma.
• Analysis of pharmacological options, primarily low-molecular weight heparins (LMWH).
• Evaluation of mechanical prophylaxis methods and their role in conjunction with pharmacological agents.

Main Results:

• Low-molecular weight heparin (LMWH) prophylaxis, initiated once primary hemostasis is achieved, is safe and effective in the majority of trauma patients, including those with traumatic brain injury (TBI).
• Mechanical prophylaxis alone offers suboptimal protection and is recommended primarily as an adjunct to LMWH when bleeding is uncontrolled.
• Established protocols for LMWH administration (once or twice daily) can be implemented throughout the hospital stay.

Conclusions:

• Routine VTE prophylaxis is a standard of care in trauma patients.
• LMWH is a safe, efficacious, and cost-effective method for VTE prevention in trauma.
• Timely initiation of LMWH after achieving hemostasis is crucial for mitigating VTE risk without compromising patient safety.